<DOC>
	<DOCNO>NCT00443521</DOCNO>
	<brief_summary>The purpose study evaluate intravitreal injection triamcinolone acetonide laser panretinal photocoagulation treatment proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Triamcinolone Adjunctive Treatment Laser Panretinal Photocoagulation Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description>The current gold standard treatment proliferative diabetic retinopathy panretinal photocoagulation . Therefore study design use treatment patient : intravitreal triamcinolone plus panretinal photocoagulation one eye , compare panretinal photocoagulation alone contralateral eye . These patient visual acuity measure complete ophthalmological examination perform , include macular slit lamp examination , fluorescein angiography optical coherence tomography . Patients symmetric proliferative diabetic retinopathy without high risk characteristic receive laser therapy eye triamcinolone injection one eye . For triamcinolone injection , numb drop , antibiotic drop , drop dilate pupil , possibly anesthetic injection , put eye medicine inject vitreous . Patients return follow-up visit 1 day , 1 4 week injection , 3 6 month . Patients whose condition improve may undergo new evaluation .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Type II Diabetes symmetric proliferative diabetic retinopathy without high risk characteristic Informed consent sign previous treatment diabetic retinopathy medium opacity may interfere clinical , photographically OCT examination inability understand implication protocol Glaucoma ocular hypertension Any pathology could cause retinal alteration Patients situation may interfere study completion base InvestigatorÂ´s opinion</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Diabetes Mellitus/ complication</keyword>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Laser coagulation</keyword>
	<keyword>Tomography , optical coherence</keyword>
</DOC>